Benzinga | Nov 12, 2021 07:22AM EST

Gain Therapeutics Q3 EPS $(0.39) Down From $(0.25) YoY, Sales $27.34M Up From $6.70M YoY

Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.39) per share. This is a 56 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $27.34 million in sales this quarter. This is a 308.38 percent increase over sales of $6.70 million the same period last year.